房颤初级保健整合管理:ALL-IN整群随机试验结果
ALL-IN试验在荷兰初级保健机构开展整群随机、开放标签、实用性非劣效性研究,将26家诊所随机分为整合照护干预组(15家)与常规照护组(11家)。干预组941例≥65岁合格房颤患者中527例签署知情同意并接受干预,与对照组713例常规照护患者比较;中位年龄77岁(四分位距72-83)。随访2年全因死亡率为干预组每100患者年3.5例 vs 对照组6.7例(校正HR 0.55;95%CI 0.37-0.82),心血管外死亡校正HR 0.47(95%CI 0.27-0.82),其他不良事件无统计学显著差异。
要点
- 初级保健护士每季度房颤随访并关注可能干扰的合并症,可降低老年房颤患者全因死亡风险。
- 干预包含初级保健抗凝监测及心内科与抗凝门诊便捷会诊支持。
- 全因死亡率干预组每100患者年3.5例 vs 对照组6.7例,校正HR 0.55(95%CI 0.37-0.82)。
核心结论
- 在初级保健中对老年房颤患者实施整合照护,与常规照护相比全因死亡率降低45%。
研究设计与样本
- ALL-IN为在荷兰初级保健诊所开展的整群随机、开放标签、实用性非劣效性试验,共随机26家诊所(干预15家、对照11家)。
- 干预组941例≥65岁合格房颤患者中527例签署知情同意接受干预,对照组713例接受常规照护,中位年龄77岁(四分位距72-83)。
- 干预由三部分组成:初级保健培训护士每季度房颤检查并关注可能干扰的合并症、初级保健抗凝治疗监测、心内科与抗凝门诊会诊的便捷可及。
- 主要终点为2年随访期间全因死亡率。
主要发现
- 全因死亡率为干预组每100患者年3.5例 vs 对照组每100患者年6.7例,校正HR 0.55(95%CI 0.37-0.82)。
- 心血管外死亡校正HR为0.47(95%CI 0.27-0.82)。
- 其他不良事件未观察到统计学显著差异。
临床怎么用
- 对老年房颤患者可在初级保健层面以护士主导的季度随访、抗凝监测与心内科便捷会诊组合实施整合照护。
- 整合照护方案在本试验中与全因死亡风险降低相关,其他不良事件无显著差异,可作为初级保健房颤管理模式的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate whether integrated care for atrial fibrillation (AF) can be safely orchestrated in primary care. METHODS AND RESULTS: The ALL-IN trial was a cluster randomized, open-label, pragmatic non-inferiority trial performed in primary care practices in the Netherlands. We randomized 26 practices: 15 to the integrated care intervention and 11 to usual care. The integrated care intervention consisted of (i) quarterly AF check-ups by trained nurses in primary care, also focusing on possibly interfering comorbidities, (ii) monitoring of anticoagulation therapy in primary care, and finally (iii) easy-access availability of consultations from cardiologists and anticoagulation clinics. The primary endpoint was all-cause mortality during 2 years of follow-up. In the intervention arm, 527 out of 941 eligible AF patients aged ≥65 years provided informed consent to undergo the intervention. These 527 patients were compared with 713 AF patients in the control arm receiving usual care. Median age was 77 (interquartile range 72-83) years. The all-cause mortality rate was 3.5 per 100 patient-years in the intervention arm vs. 6.7 per 100 patient-years in the control arm [adjusted hazard ratio (HR) 0.55; 95% confidence interval (CI) 0.37-0.82]. For non-cardiovascular mortality, the adjusted HR was 0.47 (95% CI 0.27-0.82). For other adverse events, no statistically significant differences were observed. CONCLUSION: In this cluster randomized trial, integrated care for elderly AF patients in primary care showed a 45% reduction in all-cause mortality when compared with usual care.
引用
- van den Dries CJ, van Doorn S, Rutten FH, et al. Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial. Eur Heart J. 2020. PMID: 32112556. doi:10.1093/eurheartj/ehaa055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。